BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32414636)

  • 41. [Renal insufficiency and clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a multi-centre study].
    Huo Y; Ho W
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 39(6):624-9. PubMed ID: 18087555
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Gender on Unplanned Readmissions After Percutaneous Coronary Intervention (from the Nationwide Readmissions Database).
    Kwok CS; Potts J; Gulati M; Alasnag M; Rashid M; Shoaib A; Ul Haq MA; Bagur R; Mamas MA
    Am J Cardiol; 2018 Apr; 121(7):810-817. PubMed ID: 29448978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ADVANCIS Score Predicts Acute Kidney Injury After Percutaneous Coronary Intervention for Acute Coronary Syndrome.
    Fan PC; Chen TH; Lee CC; Tsai TY; Chen YC; Chang CH
    Int J Med Sci; 2018; 15(5):528-535. PubMed ID: 29559842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Double product reflects the association of heart rate with MACEs in acute coronary syndrome patients treated with percutaneous coronary intervention.
    Xu T; Zhan Y; Lu N; He Z; Su X; Tan X
    BMC Cardiovasc Disord; 2017 Dec; 17(1):284. PubMed ID: 29197333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trends and Outcomes After Same-Day Discharge After Percutaneous Coronary Interventions.
    Agarwal S; Thakkar B; Skelding KA; Blankenship JC
    Circ Cardiovasc Qual Outcomes; 2017 Aug; 10(8):. PubMed ID: 28794119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends and predictors of rehospitalisation following an acute coronary syndrome: report from the Australian and New Zealand population of the Global Registry of Acute Coronary Events (GRACE).
    Sangu PV; Ranasinghe I; Aliprandi Costa B; Devlin G; Elliot J; Lefkovitz J; Brieger D
    Heart; 2012 Dec; 98(23):1728-31. PubMed ID: 23010286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors and etiologies of 30-day readmissions in patients with non-ST-elevation acute coronary syndrome.
    Lemor A; Hernandez GA; Patel N; Blumer V; Sud K; Cohen MG; De Marchena E; Kini AS; Sharma SK; Alfonso CE
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):373-379. PubMed ID: 30280472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. National Trends and Outcomes of Percutaneous Coronary Intervention in Patients ≥70 Years of Age With Acute Coronary Syndrome (from the National Inpatient Sample Database).
    Elbadawi A; Elgendy IY; Ha LD; Mahmoud K; Lenka J; Olorunfemi O; Reyes A; Ogunbayo GO; Saad M; Abbott JD
    Am J Cardiol; 2019 Jan; 123(1):25-32. PubMed ID: 30360891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sex-Specific Treatment Effects After Primary Percutaneous Intervention: A Study on Coronary Blood Flow and Delay to Hospital Presentation.
    Cenko E; van der Schaar M; Yoon J; Kedev S; Valvukis M; Vasiljevic Z; Ašanin M; Miličić D; Manfrini O; Badimon L; Bugiardini R
    J Am Heart Assoc; 2019 Feb; 8(4):e011190. PubMed ID: 30764687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discharge Against Medical Advice After Percutaneous Coronary Intervention in the United States.
    Kwok CS; Bell M; Anderson HV; Al Shaibi K; Gulati R; Potts J; Rashid M; Kontopantelis E; Bagur R; Mamas MA
    JACC Cardiovasc Interv; 2018 Jul; 11(14):1354-1364. PubMed ID: 30025729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Late Potential as a Predictor of re-Hospitalization after Percutaneous Coronary Intervention for Acute Coronary Syndrome.
    Nakamura M; Yoshioka K; Amino M; Watanabe E; Fujii T; Hashida T; Fujibayashi D; Kanda S; Kobayashi Y; Tanabe T; Ikari Y
    Tokai J Exp Clin Med; 2016 Dec; 41(4):172-180. PubMed ID: 27988914
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical outcomes after percutaneous coronary intervention in non-dialysis patients with acute coronary syndrome and advanced renal dysfunction.
    Uemura Y; Ishikawa S; Takemoto K; Negishi Y; Tanaka A; Takagi K; Yoshioka N; Umemoto N; Inoue Y; Morishima I; Shibata N; Asano H; Ishii H; Watarai M; Murohara T;
    Clin Exp Nephrol; 2020 Apr; 24(4):339-348. PubMed ID: 31903510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombomodulin can predict the incidence of second events in patients with acute coronary syndrome: Single-center, retrospective cohort study.
    Kosaki R; Minoura Y; Ogura K; Oishi Y; Tanaka L; Arai K; Nomura K; Sakai K; Sekimoto T; Nisikura T; Tsujita H; Kondo S; Tsukamoto S; Hamazaki Y; Kobayashi Y
    J Cardiol; 2018 Dec; 72(6):494-500. PubMed ID: 29887328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Turgeon RD; Koshman SL; Youngson E; Har B; Wilton SB; James MT; Graham MM
    JAMA Intern Med; 2020 Mar; 180(3):420-428. PubMed ID: 31930361
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of prior permanent pacemaker on long-term clinical outcomes of patients undergoing percutaneous coronary intervention.
    Li YJ; Zhang WW; Yang XX; Li N; Qiu XB; Qu XK; Fang WY; Yang YQ; Li RG
    Clin Cardiol; 2017 Apr; 40(4):205-209. PubMed ID: 27879000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heart rate at discharge and long-term prognosis following percutaneous coronary intervention in stable and acute coronary syndromes--results from the BASKET PROVE trial.
    Jensen MT; Kaiser C; Sandsten KE; Alber H; Wanitschek M; Iversen A; Jensen JS; Pedersen S; Soerensen R; Rickli H; Zurek M; Fahrni G; Bertel O; De Servi S; Erne P; Pfisterer M; Galatius S;
    Int J Cardiol; 2013 Oct; 168(4):3802-6. PubMed ID: 23849965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypertension is associated with increased mortality in patients with ischaemic heart disease after revascularization with percutaneous coronary intervention - a report from SCAAR.
    Saluveer O; Redfors B; Angerås O; Dworeck C; Haraldsson I; Ljungman C; Petursson P; Odenstedt J; Ioanes D; Lundgren P; Völz S; Råmunddal T; Andersson B; Omerovic E; Bergh N
    Blood Press; 2017 Jun; 26(3):166-173. PubMed ID: 28092977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prediction model to identify patients at high risk for 30-day readmission after percutaneous coronary intervention.
    Wasfy JH; Rosenfield K; Zelevinsky K; Sakhuja R; Lovett A; Spertus JA; Wimmer NJ; Mauri L; Normand SL; Yeh RW
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):429-35. PubMed ID: 23819957
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Personality and Psychological Stress Predict Major Adverse Cardiovascular Events in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention for Five Years.
    Du J; Zhang D; Yin Y; Zhang X; Li J; Liu D; Pan F; Chen W
    Medicine (Baltimore); 2016 Apr; 95(15):e3364. PubMed ID: 27082597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Multifactorial Prognostication of the Development of Stent Thrombosis in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention on the background of Dual Antiplatelet Therapy].
    Korotaeva ES; Koroleva LY; Nosov VP; Kovaleva GV; Kuzmenko EA
    Kardiologiia; 2019 Dec; 59(11):5-13. PubMed ID: 31849294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.